MCL0129 is a selective and non-peptidergic melanocortin 4 (MC4) receptor antagonist. It is a a potential treatment for cachexia. References: Foster AC, Chen C, Markison S, Marks DL. MC4 receptor antagonists: a potential treatment for cachexia. IDrugs. 2005 Apr;8(4):314-9. Review. PubMed PMID: 15800806.

纯度：≥98%

CAS：768357-45-5